Pre-clinical Studies

Scientists discover potential druggable target for lung cancer treatment

Scientists in the UK claim to have identified a crucial molecular player in a subtype of lung cancer that could pave way for a new approach towards treating the condition.

Study finds new drug treatment could reduce liver transplants

Scientists in the UK believe that patients with sudden liver failure could benefit from a new treatment in the future that could cut down the need for transplants by preventing a process called senescence with certain anti-cancer therapy drugs.

Oxford BioMedica forms three-way partnership for cystic fibrosis treatment

Oxford BioMedica has collaborated with the UK Cystic Fibrosis Gene Therapy Consortium (GTC) and Imperial Innovations for the development of a long-term therapy to treat patients with cystic fibrosis.

Kalytera scraps pre-clinical programs in bone disease

Kalytera Therapeutics has announced the termination of its pre-clinical development programs in the treatment of bone disease to focus its resources on graft versus host disease (GVHD) and pain programs.

Onxeo unveils encouraging results from preclinical studies of Livatag in pancreatic cancer

Biopharmaceutical firm Onxeo has announced encouraging results from a series of preclinical studies evaluating Livatag interest for pancreatic cancer.